We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$4.17B
AUM Growth
-$194M
Cap. Flow
-$171M
Cap. Flow %
-4.1%
Top 10 Hldgs %
18.88%
Holding
577
New
17
Increased
140
Reduced
287
Closed
51

Top Buys

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$23.2M
2
MSFT icon
Microsoft
MSFT
+$19.5M
3
IEX icon
IDEX
IEX
+$10.7M
4
PM icon
Philip Morris
PM
+$6.74M
5
ZTS icon
Zoetis
ZTS
+$6.45M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 15.71%
3 Healthcare 11.87%
4 Industrials 9.59%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FICO icon
26
Fair Isaac
FICO
$24.3B
$36M 0.86%
24,216
+57
+0.2% +$73.7K
WSO icon
27
Watsco Inc
WSO
$12.7B
$35.6M 0.85%
76,794
-310
-0.4% -$142K
COO icon
28
Cooper Companies
COO
$14.1B
$35.2M 0.84%
403,024
+712
+0.2% +$66.5K
NDSN icon
29
Nordson
NDSN
$16.6B
$35.1M 0.84%
151,502
-883
-0.6% -$223K
EW icon
30
Edwards Lifesciences
EW
$49.6B
$34.2M 0.82%
370,431
-7,899
-2% -$699K
ENTG icon
31
Entegris
ENTG
$18.1B
$33.7M 0.81%
248,826
-3,031
-1% -$400K
EQIX icon
32
Equinix
EQIX
$101B
$33.2M 0.8%
43,865
+262
+0.6% +$199K
AME icon
33
Ametek
AME
$55.4B
$30.1M 0.72%
180,500
-717
-0.4% -$124K
DIS icon
34
Walt Disney
DIS
$167B
$29.8M 0.71%
299,910
-2,157
-0.7% -$232K
CW icon
35
Curtiss-Wright
CW
$26.7B
$29.6M 0.71%
109,322
-545
-0.5% -$146K
IJR icon
36
iShares Core S&P Small-Cap ETF
IJR
$109B
$27.4M 0.66%
257,153
+821
+0.3% +$87.8K
MRK icon
37
Merck
MRK
$322B
$27.3M 0.65%
220,424
-7,735
-3% -$996K
SCHM icon
38
Schwab US Mid-Cap ETF
SCHM
$14.5B
$26.4M 0.63%
1,018,746
+16,236
+2% +$425K
VRSK icon
39
Verisk Analytics
VRSK
$25.4B
$26.1M 0.62%
96,680
+94,640
+4,639% +$23.2M
CME icon
40
CME Group
CME
$96.3B
$26M 0.62%
132,132
-5,447
-4% -$1.13M
EXP icon
41
Eagle Materials
EXP
$6.29B
$25.2M 0.6%
115,989
-1,628
-1% -$399K
JKHY icon
42
Jack Henry & Associates
JKHY
$10.9B
$24.3M 0.58%
146,157
+25,556
+21% +$4.24M
EMXC icon
43
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
$24M 0.58%
405,056
+3,074
+0.8% +$177K
INTU icon
44
Intuit
INTU
$86.5B
$23.3M 0.56%
35,457
-965
-3% -$599K
WST icon
45
West Pharmaceutical
WST
$24B
$23.1M 0.55%
70,036
+326
+0.5% +$115K
SCHD icon
46
Schwab US Dividend Equity ETF
SCHD
$103B
$22.9M 0.55%
884,151
-64,020
-7% -$1.67M
EFA icon
47
iShares MSCI EAFE ETF
EFA
$78B
$22.7M 0.54%
289,553
-10,210
-3% -$809K
AVY icon
48
Avery Dennison
AVY
$13B
$22.7M 0.54%
103,591
-7,988
-7% -$1.77M
PEP icon
49
PepsiCo
PEP
$190B
$22.5M 0.54%
136,135
+337
+0.2% +$58.2K
EOG icon
50
EOG Resources
EOG
$79.2B
$22.4M 0.54%
178,120
-6,829
-4% -$876K

Similar funds

Curi RMB Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Curi RMB Capital held 577 positions worth $4.17B, down 4.4% from $4.36B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Curi RMB Capital withdrew a net $171M in Q2 2024, closing 51 positions and reducing 287 holdings. Its most notable exit was Teledyne Technologies, an estimated $3.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Curi RMB Capital opened a new position in Abacus Global Management worth $4.65M.

  • Curi RMB Capital's largest Q2 2024 buy was Abacus Global Management: 537,235 shares worth $4.65M.
  • Curi RMB Capital added most to Verisk Analytics in Q2 2024, an estimated $23.2M increase.
  • Curi RMB Capital's biggest Q2 2024 reduction was Fortune Brands Innovations, cutting an estimated $20.8M.
  • Curi RMB Capital fully exited Teledyne Technologies in Q2 2024, selling an estimated $3.74M.
  • Curi RMB Capital's ten largest holdings make up 19% of its $4.17B portfolio in Q2 2024.
  • Curi RMB Capital opened 17 new positions and closed 51 in Q2 2024.
  • Curi RMB Capital's portfolio value fell 4.4% quarter-over-quarter to $4.17B.

Based on Curi RMB Capital's 13F filing for Q2 2024, filed 13 Aug 2024.